EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC-ND 4.0

Shared Genetic Risk Factors for Multiple Sclerosis /Psoriasis Suggest Involvement of Interleukin‐17 and Janus Kinase–Signal Transducers and Activators of Transcription Signaling

Matthew T Patrick iD, Rajan P Nair, Kevin He, Philip E Stuart, Allison C Billi, Xiang Zhou, Johann E Gudjonsson, Jorge R Oksenberg, James T Elder, Lam C Tsoi

Annals of Neurology · 2023

DOI: 10.1002/ana.26672 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Annals of Neurology, 2023. Verfasst von Matthew T Patrick und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Psoriasis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, Dermatology Foundation, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Psoriasis and multiple sclerosis (MS) are complex immune diseases that are mediated by T cells and share multiple comorbidities. Previous studies have suggested psoriatic patients are at higher risk of MS; however, causal relationships between the two conditions remain unclear. Through epidemiology and genetics, we provide a comprehensive understanding of the relationship, and share molecular factors between psoriasis and MS.

Methods

We used logistic regression, trans‐disease meta‐analysis and Mendelian randomization. Medical claims data were included from 30 million patients, including 141,544 with MS and 742,919 with psoriasis. We used genome‐wide association study summary statistics from 11,024 psoriatic, 14,802 MS cases, and 43,039 controls for trans‐disease meta‐analysis, with additional summary statistics from 5 million individuals for Mendelian randomization.

Results

Psoriatic patients have a significantly higher risk of MS (4,637 patients with both diseases; odds ratio [OR] 1.07, p = 1.2 × 10 −5 ) after controlling for potential confounders. Using inverse variance and equally weighted trans‐disease meta‐analysis, we revealed >20 shared and opposing (direction of effect) genetic loci outside the major histocompatibility complex that showed significant genetic colocalization (in COLOC and COLOC‐SuSiE v5.1.0). Co‐expression analysis of genes from these loci further identified distinct clusters that were enriched among pathways for interleukin‐17/tumor necrosis factor‐α (OR >39, p < 1.6 × 10 −3 ) and Janus kinase–signal transducers and activators of transcription (OR 35, p = 1.1 × 10 −5 ), including genes, such as TNFAIP3 , TYK2 , and TNFRSF1A . Mendelian randomization found psoriasis as an exposure has a significant causal effect on MS (OR 1.04, p = 5.8 × 10 −3 ), independent of type 1 diabetes (OR 1.05, p = 4.3 × 10 −7 ), type 2 diabetes (OR 1.08, p = 2.3 × 10 −3 ), inflammatory bowel disease (OR 1.11, p = 1.6 × 10 −11 ), and vitamin D level (OR 0.75, p = 9.4 × 10 −3 ).

Interpretation

By investigating the shared genetics of psoriasis and MS, along with their modifiable risk factors, our findings will advance innovations in treatment for patients suffering from comorbidities. ANN NEUROL 2023;94:384–397

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisPsoriasisHumansDiabetes Mellitus, Type 2Genome-Wide Association StudyInterleukin-17Mendelian Randomization AnalysisPolymorphism, Single NucleotideRisk FactorsJanus KinasesSTAT Transcription Factors

Substanzen

Interleukin-17Janus KinasesSTAT Transcription Factors

Autor:innen und Institutionen

  • Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
  • Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Matthew T Patrick

Förderung

  • NIAMS NIH HHS
  • Dermatology Foundation
  • Foundation for the National Institutes of Health
  • National Psoriasis Foundation

Zitieren

APA

Patrick, M. T., Nair, R. P., He, K., Stuart, P. E., Billi, A. C., Zhou, X., Gudjonsson, J. E., Oksenberg, J. R., Elder, J. T., & Tsoi, L. C. (2023). Shared Genetic Risk Factors for Multiple Sclerosis /Psoriasis Suggest Involvement of Interleukin‐17 and Janus Kinase–Signal Transducers and Activators of Transcription Signaling. Annals of Neurology. https://doi.org/10.1002/ana.26672

Vancouver

Patrick MT, Nair RP, He K, Stuart PE, Billi AC, Zhou X, et al. Shared Genetic Risk Factors for Multiple Sclerosis /Psoriasis Suggest Involvement of Interleukin‐17 and Janus Kinase–Signal Transducers and Activators of Transcription Signaling. Annals of Neurology. 2023. doi:10.1002/ana.26672

BibTeX
@article{Patrick2023,
  author = {Patrick, Matthew T and Nair, Rajan P and He, Kevin and Stuart, Philip E and Billi, Allison C and Zhou, Xiang and Gudjonsson, Johann E and Oksenberg, Jorge R and Elder, James T and Tsoi, Lam C},
  title = {Shared Genetic Risk Factors for Multiple Sclerosis /Psoriasis Suggest Involvement of Interleukin‐17 and Janus Kinase–Signal Transducers and Activators of Transcription Signaling},
  journal = {Annals of Neurology},
  year = {2023},
  doi = {10.1002/ana.26672}
}
Kostenlos starten →